-
May 4, 2021 Promising Results from First Phase-3 Trial Investigating MDMA-Assisted Therapy for PTSDThe first phase-3 trial of its kind investigating MDMA for PTSD is showing promising results.
-
May 3, 2021 Researchers Discover Therapeutic Potential of Non-Hallucinogenic PsychedelicResearchers have identified a psychedelic with no hallucinogenic characteristics using a new sensor.
-
May 3, 2021 Former NFL Player Kerry Rhodes Discusses Ayahuasca Experience With Tamron HallActor and former NFL safety Kerry Rhodes says the psychedelic compound ayahuasca has helped him...
-
April 30, 2021 Psilocybin Provides Long-Term Relief of Cancer-Related Anxiety, Depression: StudyA follow-up study has found long-term relief from anxiety and depression related to cancer diagnoses...
-
April 30, 2021 Psychedelic Business News Spotlight: April 30, 2021This week in psychedelic business news: Cybin’s experimental psychedelic takes aim at alcohol use disorder,...
-
April 29, 2021 First-of-Its-Kind 5-MeO-DMT Psychedelic Training Underscores New Research PotentialBeckley Psytech and Fluence have partnered on a first of its kind training for 5-meo-DMT...
-
April 28, 2021 PharmaTher Files Patent on Ketamine for Diabetes and Obesity TreatmentKetamine may be a useful treatment for diabetes and obesity, according to a new patent...
-
April 27, 2021 Who Is Stanislav Grof? Meet the Psychedelic Pioneer and Father of Holotropic BreathworkStanislav Grof is one of the earliest pioneers in psychedelics and holotropic breathwork.
-
April 27, 2021 New Campaign to Raise Awareness of Healing Power of Psychedelics for VeteransA new campaign, #natureheals promotes psychedelics for veterans suffering from PTSD and other mental health...
-
April 26, 2021 Kevin O’Leary-Backed MindMed Will Be 2nd Psychedelic Company to List On NasdaqMindMed will take its Kevin O'Leary-backed platform onto the Nasdaq Tuesday as only the 2nd...
